← Leaderboards
Jochen Buck
Weill Medical College Of Cornell Univ
$16,607,665
Attributed
$25,090,837
Total exposure
13
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.5M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$37,054,647 · 15
By mechanism
R01$19,494,349 · 8
P50$16,836,028 · 5
R21$475,625 · 1
U54$248,645 · 1
Top collaborators
- Lonny R Levin38 shared
- Pablo Eduardo Visconti10 shared
Most similar at Weill Medical College Of Cornell Univ
Same institution · by research overlap
- Lonny R Levin$17,449,947
Others in their field
Top investigators on “Adenylate Cyclase”
- Stephen F Vatner · Univ Of Med/Dent Of Nj-Nj Medical School$15,473,498
- Lonny R Levin · Weill Medical College Of Cornell Univ$15,462,855
- Dennis Brown · Massachusetts General Hospital$13,042,858
- Daniel R Storm · University Of Washington$11,877,486
- Pedro A. Jose · George Washington University$10,827,484
- H. Kirk Hammond · University Of California San Diego$9,009,378
Research focus
Adenylate CyclaseBicarbonatesSperm CellCyclic AmpEpididymisKnock-OutSecond Messenger SystemsInhibitor/AntagonistMalePhenotypeMolecularGeneticKnockout MiceResponseEjaculationSourceMediatingBiochemicalCellsPropertySignal TransductionEquilibriumExhibitsRegulation
Grant awards (63)
On-demand nonhormonal male contraception via ADCY10 inhibition$1,999,520
P50 · FY2025 · HD
Comparative studies on the regulation of metabolism during sperm capacitation$694,239
R01 · FY2025 · HD · contact PI
Optimization of lead candidates for an on-demand male contraceptive$687,095
R01 · FY2025 · HD · contact PI
Assessing inhibitor efficacy in vivo and developing a biomarker for use during early phase clinical trials$601,603
P50 · FY2025 · HD · contact PI
Development of new ADCY10 inhibitors$496,574
P50 · FY2025 · HD · contact PI
On-demand nonhormonal male contraception via ADCY10 inhibition$1,999,520
P50 · FY2024 · HD
Comparative studies on the regulation of metabolism during sperm capacitation$693,491
R01 · FY2024 · HD · contact PI
Optimization of lead candidates for an on-demand male contraceptive$682,405
R01 · FY2024 · HD · contact PI
Assessing inhibitor efficacy in vivo and developing a biomarker for use during early phase clinical trials$601,603
P50 · FY2024 · HD · contact PI
Development of new ADCY10 inhibitors$496,574
P50 · FY2024 · HD · contact PI
On-demand nonhormonal male contraception via ADCY10 inhibition$1,999,520
P50 · FY2023 · HD
Comparative studies on the regulation of metabolism during sperm capacitation$705,984
R01 · FY2023 · HD · contact PI
Optimization of lead candidates for an on-demand male contraceptive$689,299
R01 · FY2023 · HD · contact PI
Assessing inhibitor efficacy in vivo and developing a biomarker for use during early phase clinical trials$601,603
P50 · FY2023 · HD · contact PI
Development of new ADCY10 inhibitors$496,574
P50 · FY2023 · HD · contact PI
Comparative studies on the regulation of metabolism during sperm capacitation$746,828
R01 · FY2022 · HD · contact PI
High Throughput screen to identify "first of their kind" activators of ADCY10$569,432
R01 · FY2022 · AG
On-Demand Pharmacological Contraception by Blocking ADCY 10$1,982,625
P50 · FY2021 · HD
High Throughput screen to identify "first of their kind" activators of ADCY10$569,432
R01 · FY2021 · AG
Development of new ADCY10 inhibitors$520,104
P50 · FY2021 · HD · contact PI
Crosstalk between metabolic and signaling pathways involved in sperm capacitation$475,372
R01 · FY2021 · HD · contact PI
On-Demand Pharmacological Contraception by Blocking ADCY 10$1,982,625
P50 · FY2020 · HD
High Throughput screen to identify "first of their kind" activators of ADCY10$588,072
R01 · FY2020 · AG
Development of new ADCY10 inhibitors$520,104
P50 · FY2020 · HD · contact PI
Crosstalk between metabolic and signaling pathways involved in sperm capacitation$501,946
R01 · FY2020 · HD · contact PI
On-Demand Pharmacological Contraception by Blocking ADCY 10$2,000,000
P50 · FY2019 · HD
High Throughput screen to identify "first of their kind" activators of ADCY10$566,037
R01 · FY2019 · AG
Crosstalk between metabolic and signaling pathways involved in sperm capacitation$557,490
R01 · FY2019 · HD · contact PI
Development of new ADCY10 inhibitors$537,479
P50 · FY2019 · HD · contact PI
Crosstalk between metabolic and signaling pathways involved in sperm capacitation$485,074
R01 · FY2018 · HD · contact PI
Crosstalk between metabolic and signaling pathways involved in sperm capacitation$55,306
R01 · FY2018 · HD · contact PI
Crosstalk between metabolic and signaling pathways involved in sperm capacitation$474,312
R01 · FY2017 · HD · contact PI
Metabolic regulation via intramitochondrial sAC$377,985
R01 · FY2017 · GM
Metabolic regulation via intramitochondrial sAC$377,985
R01 · FY2016 · GM
Modulating intraocular pressure to treat ocular hypotony and glaucoma$249,000
R21 · FY2016 · EY · contact PI
Metabolic regulation via intramitochondrial sAC$377,985
R01 · FY2015 · GM
Modulating intraocular pressure to treat ocular hypotony and glaucoma$226,625
R21 · FY2015 · EY · contact PI
Metabolic regulation via intramitochondrial sAC$377,985
R01 · FY2014 · GM
Bicarbonate regulated adenylyl cyclase$407,105
R01 · FY2013 · GM · contact PI
Soluble adenylyl cyclase isoforms essential for male fertility$316,284
R01 · FY2013 · HD
Bicarbonate regulated adenylyl cyclase$421,797
R01 · FY2012 · GM · contact PI
Soluble adenylyl cyclase isoforms essential for male fertility$333,282
R01 · FY2012 · HD
Bicarbonate regulated adenylyl cyclase$421,725
R01 · FY2011 · GM · contact PI
Soluble adenylyl cyclase isoforms essential for male fertility$333,282
R01 · FY2011 · HD
Bicarbonate regulated adenylyl cyclase$511,041
R01 · FY2010 · GM · contact PI
Soluble adenylyl cyclase isoforms essential for male fertility$347,168
R01 · FY2010 · HD
Soluble adenylyl cyclase isoforms essential for male fertility$348,600
R01 · FY2009 · HD
Bicarbonate regulated adenylyl cyclase$346,648
R01 · FY2009 · GM · contact PI
Bicarbonate regulated adenylyl cyclase$84,177
R01 · FY2009 · GM · contact PI
Bicarbonate regulated adenylyl cyclase$346,648
R01 · FY2008 · GM · contact PI
Inhibition of Adenylyl Cyclase for Treatment of Enteropathogenic Bacteria$248,645
U54 · FY2008 · AI · contact PI
Bicarbonate regulated adenylyl cyclase$346,648
R01 · FY2007 · GM · contact PI
Bicarbonate regulated adenylyl cyclase$357,000
R01 · FY2006 · GM · contact PI
Physiological isoforms of sAC in male germ cells$305,100
R01 · FY2005 · HD
BICARBONATE REGULATED ADENYLYL CYCLASE$350,018
R01 · FY2004 · GM
Physiological isoforms of sAC in male germ cells$305,100
R01 · FY2004 · HD
BICARBONATE REGULATED ADENYLYL CYCLASE$350,018
R01 · FY2003 · GM
Physiological isoforms of sAC in male germ cells$305,100
R01 · FY2003 · HD
BICARBONATE REGULATED ADENYLYL CYCLASE$350,018
R01 · FY2002 · GM
Physiological isoforms of sAC in male germ cells$305,100
R01 · FY2002 · HD
BICARBONATE REGULATED ADENYLYL CYCLASE$350,018
R01 · FY2001 · GM
Physiological isoforms of sAC in male germ cells$305,100
R01 · FY2001 · HD
INTRACELLULAR TARGETS IN RETRO RETINOID SIGNALING$393,618
R01 · FY2000 · DK